'Quite hopeful': Abortion pill decision could reshape reproductive health war
Regulators are due to decide Thursday whether to uphold, revise or scrap longstanding restrictions on the abortion drug mifepristone.
As the Supreme Court weighs the fate of Roe v. Wade, the Food and Drug Administration is set to open a new phase in the abortion wars this week, when it issues a key decision on how doctors can dispense pills to end an early pregnancy.
